Which IB has the best rep in HK?
Which IB has the best rep in HK?
Trending Content - Investment Banking Forum
| +190 | Evercore > Goldman and I don’t think it’s particularly close anymore | 65 | 21h |
| +157 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +87 | Think Twice before Recruiting for HOUSTON IB!! | 44 | 8h |
| +86 | UBS Offer Day | 32 | 4h |
| +71 | I hate Wells Fargo | 19 | 1d |
| +52 | No return offer - feeling like a failure is an understatement | 21 | 11h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 1d |
| +47 | WF Return offers | 28 | 3d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
| +39 | Should I go back into a junior IBD role for comp? | 16 | 3d |
Career Resources
Piper Jaffray.
Why don't you check the league tables? Assuming that by reputation you mean deal volume.
Pretty much same thing as US... The european banks are relatively stronger there than they are in the US (UBS, CS, DB). BAML and Citi are pretty mediocre. GS/MS/JPM still are probably the most "prestigious"
One thing to keep in mind though is that in HK, it's probably better to join an industry coverage team versus a product group (i.e. M&A). ECM is the money maker in Asia, a lot of regulatory and cultural problems that hinders M&A deal volume. Financial Sponsors/LevFin = no dealflow. Equity-related deals, by contrast, are very common.
GS MS UBS CS
whats wrong with PJC? They led couple of deals in HK.
GS, MS and UBS
MS and UBS are very strong in HK/China market. GS has been losing market shares in the past few years, but still has great business presence. JPM and CS has been catching up in the past two years, especially JPM. Citi and DB are mediocore in HK/China. ML has been growing in Asia, but not sure how the new BAML looks like right now. BarCap, Lehman and Bear used to be the worst BB shops in HK. BarCap has very small market share in HK/China due to their focus on debt products. It is going to take a long time for them to establish their M&A and equity business in full there. Lehman just don't have a good business rhythm outside the US territory... Now the Nomura thing makes it look even worse IMO. Bear is out of discussion now.
Thanks for all the replies
UBS is tops
gs, ms, jpm, ubs, cs
ubs used to be rank higher in terms of prestige (altho its still number 1 in ECM, its rep has been damaged since the crisis)
agree that db is pretty mediocre
bump! wondering if the situation is still the same
UBS is still top
UBS going down
bump
has anything changed?
anyone?
GS, MS, BAML and CS are top
Citi and UBS are mediocre
Don't go near DB right now
UBS and Barcap don't have much presence here anymore
As stated above, its better to start in a industry coverage group or M&A here as opposed to a product group - besides actually getting to learn something it is more "prestigious" and has better exit ops.
Noticed you've left JPM out...
JPM is between the top and mediocre bucket now - owing to recent investigations and structural changes. Bonuses at JPM were terrible this year
Also that UBS is hiring there and was top or second on the league tables...
True UBS is hiring, but doesn't have much brand value here compared to the other BBs.
Besides the fact that LTs don't really mean anything, the LTs here are mainly dominated by the local banks and some from the top bracket of banks. Anyone can get on the top by joint-bookrunning hundreds of deals
I'm giving you an on ground view here, as recent as last year. Again this is my opinion, but a general consensus across other analysts from other banks here
GS, MS and UBS
UBS is No1 in mainland China thanks to its JV and set of licenses, ok-ish in Hong Kong
That's a Yes, from what I hear. M&A in general does better here in HK
I see. Thanks for all the replies. You might not be comfortable answering this, but if you don't mind me asking, which BB did you work at?
WhartonOrBust are you going to MS HK? I am debating between a couple of options right now
Pretty inaccurate comments in this thread. UBS and GS are the only two with a real China JV. They do plenty of business and M&A wise (cross-border) GS is crushing it. MS is always going to be up there. UBS is only good because of its private wealth business and is typically non-SOE business
This is not true. MS formed one of the first JVs in China with Huaxin securities in 2011. MS M&A is definitely the place to be if you want to be involved in M&A
MSHX is not on par with UBSS or GSGH. MS formed JV after breaking up with CICC and MSHX does most A shares IPOs. UBSS and GSGH are the only top JVs. HSBC is doing great recently.
HK IBD SA Offers - How to choose and how to rank those BBs there? (Originally Posted: 01/13/2013)
Dear Monkeys,
Solved - cheers. :) :) :) :)
~
Great to see you here Alex haha
~~
bump~
bump
bump bump
bump T_T
I give up... T_T
Ut non pariatur dolorum deleniti quibusdam. Eius accusantium accusantium molestias ducimus ipsa est. Asperiores voluptatem dicta consequuntur quas non aliquam qui. Ut necessitatibus rerum quia quam ullam molestiae.
Nobis aut similique sit saepe quis. Pariatur ut ut autem asperiores ut et. Sint deserunt dolorum odio minima. Eveniet est soluta deserunt quasi qui et minima impedit. Nisi sit sit est corrupti itaque eaque.
A blanditiis delectus aspernatur eum. Tenetur consequatur at in. Qui nisi deleniti doloribus illum distinctio nihil totam libero.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Dignissimos eaque vitae nesciunt ad soluta. Ullam rem alias eum.
Molestiae quo veniam fugit voluptas qui. Quis nostrum nihil aut ut deserunt quia. Dolores earum ea magni voluptatem veritatis et est. Velit nihil dolor exercitationem voluptatem ipsam aut eligendi pariatur. Nulla blanditiis sed suscipit accusamus.
Quo magni neque aut eius est. Aperiam delectus enim possimus rerum omnis. Sint expedita et molestias enim. Totam veritatis tenetur velit ducimus qui laboriosam est. Ut incidunt eaque expedita incidunt.
Et ipsa ipsam quis in voluptatem nemo accusamus. Ut corporis hic similique unde dolor aut.
Quisquam magnam facilis quod in quo mollitia nemo. Quo alias quia accusamus eaque.